These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11686022)

  • 1. Monoclonal antibody blockade of the epidermal growth factor receptor in cancer therapy.
    Huang SM; Li J; Harari PM
    Cancer Chemother Biol Response Modif; 2001; 19():339-52. PubMed ID: 11686022
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture.
    Mendelsohn J
    Clin Cancer Res; 2000 Mar; 6(3):747-53. PubMed ID: 10741693
    [No Abstract]   [Full Text] [Related]  

  • 3. EGF receptors as a target for cancer therapy.
    Mendelsohn J
    Trans Am Clin Climatol Assoc; 2004; 115():249-53; discussion 253-4. PubMed ID: 17060971
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermal growth factor receptor: a promising target in solid tumours.
    Laskin JJ; Sandler AB
    Cancer Treat Rev; 2004 Feb; 30(1):1-17. PubMed ID: 14766123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity.
    Boland WK; Bebb G
    Expert Opin Biol Ther; 2009 Sep; 9(9):1199-206. PubMed ID: 19624281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV.
    Ho DT; Wykoff-Clary S; Gross CS; Schneider D; Jin F; Kretschmer PJ; Hermiston TW
    Cancer Gene Ther; 2009 Feb; 16(2):184-94. PubMed ID: 18758433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice.
    Baradaran B; Hosseini AZ; Majidi J; Farajnia S; Barar J; Saraf ZH; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(1-2):11-6. PubMed ID: 19478394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.
    Tortora G; Ciardiello F; Gasparini G
    Nat Clin Pract Oncol; 2008 Sep; 5(9):521-30. PubMed ID: 18594498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms and targeting of colorectal cancer.
    Vanhoefer U
    Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EGF receptor blockade--a new cancer therapy].
    Nexø E; Tørring N; Sørensen BS
    Ugeskr Laeger; 2002 Feb; 164(6):777. PubMed ID: 11851187
    [No Abstract]   [Full Text] [Related]  

  • 11. [Targeting therapy directed against growth factor receptor].
    Ueda M; Abe O; Shimizu N
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1436-42. PubMed ID: 1871365
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting the epidermal growth factor receptor: a clinical reality.
    Baselga J
    J Clin Oncol; 2001 Sep; 19(18 Suppl):41S-44S. PubMed ID: 11560970
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic targeting of epidermal growth factor receptor with monoclonal antibodies.
    Siena S; Artale S; Vanzulli A; Marrapese G; Bevilacqua L; Secondino S; Sironi O; Schiavo R; Moroni M; Pedrazzoli P
    Suppl Tumori; 2002; 1(4):S46-8. PubMed ID: 12415818
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting the epidermal growth factor receptor for cancer therapy.
    Mendelsohn J
    J Clin Oncol; 2002 Sep; 20(18 Suppl):1S-13S. PubMed ID: 12235219
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gene delivery by immunogene and its application to cancer gene therapy].
    Gamou S; Chen J; Takayanagi A; Shimizu N
    Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2562-9. PubMed ID: 8584701
    [No Abstract]   [Full Text] [Related]  

  • 16. New therapeutic agents targeting the epidermal growth factor receptor.
    Baselga J
    J Clin Oncol; 2000 Nov; 18(21 Suppl):54S-9S. PubMed ID: 11060328
    [No Abstract]   [Full Text] [Related]  

  • 17. The epidermal growth factor receptor as a target for therapy.
    Harris AL
    Cancer Cells; 1990 Oct; 2(10):321-3. PubMed ID: 2282249
    [No Abstract]   [Full Text] [Related]  

  • 18. Jeremiah Metzger Lecture. Targeted cancer therapy.
    Mendelsohn J
    Trans Am Clin Climatol Assoc; 2000; 111():95-110; discussion 110-1. PubMed ID: 10881335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: do we need a better mouse trap?
    Dancey JE
    J Clin Oncol; 2004 Aug; 22(15):2975-7. PubMed ID: 15210735
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials referral resource. Clinical trials using monoclonal antibodies.
    Davis T; Streicher H; Blatner G; Cheson BD
    Oncology (Williston Park); 1998 Oct; 12(10):1479, 1482, 1487. PubMed ID: 9798201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.